|
| Protein |
|
| Gene Symbol | PYROXD2 to neXtProt (NX_Q8N2H3) |
| Description | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 |
| Chromosome | 10 |
| Location | 10q24.2 (100143322 ~ 100174941) to Ensembl |
|
|
Sequene Features : Isoforms 1, Variants 80, PTMs 0 to neXtProt Sequence Features
|
|
Gene
Ontologies |
| GO: Biological Process |
GO: Mulecular Function |
GO: Cellular Component |
|
.N/A |
.oxidoreductase activity |
.N/A |
|
|
| |
|
| Proteomic Evidences |
|
| |
|
| Release | | Protein Evidence | | Pr | | Ab | | Isoforms | | Variants | | PTMs |
|
| 2015-01-01 | | protein level | | | | | | | 1 |
| 80 |
| 0 |
|
| 2014-09-19 | | protein level | | | | | | | 1 |
| 62 |
| 0 |
|
| 2014-05-27 | | protein level | | | | | | | 1 |
| 62 |
| 0 |
|
| 2014-02-25 | | protein level | | | | | | | 1 |
| 61 |
| 0 |
|
| 2013-12-09 | | protein level | | | | | | | 1 |
| 40 |
| 0 |
|
| 2013-11-01 | | protein level | | | | | | | 1 |
| 38 |
| 0 |
|
| 2013-09-12 | | protein level | | | | | | | 1 |
| 38 |
| 0 |
|
| 2013-08-17 | | protein level | | | | | | | 1 |
| 38 |
| 0 |
|
| 2013-07-15 | | protein level | | | | | | | 1 |
| 32 |
| 0 |
|
| 2013-06-11 | | protein level | | | | | | | 1 |
| 32 |
| 0 |
|
| 2013-02-12 | | protein level | | | | | | | 1 |
| 23 |
| 0 |
|
| 2012-12-20 | | protein level | | | | | | | 1 |
| 24 |
| 0 |
|
| 2012-10-30 | | protein level | | | | | | | 1 |
| 30 |
| 0 |
|
| 2012-10-07 | | protein level | | | | | | | 1 |
| 30 |
| 0 |
|
| 2012-08-24 | | transcript level | | | | | | | 1 |
| 27 |
| 0 |
|
| 2012-07-28 | | transcript level | | | | | | | 1 |
| 27 |
| 0 |
|
| 2012-06-08 | | transcript level | | | | | | | 1 |
| 27 |
| 0 |
|
| 2012-05-07 | | transcript level | | | | | | | 1 |
| 27 |
| 0 |
|
| 2012-04-10 | | transcript level | | | | | | | 1 |
| 27 |
| 0 |
|
| 2012-01-13 | | transcript level | | | | | | | 1 |
| 15 |
| 0 |
|
| 2011-12-20 | | transcript level | | | | | | | 1 |
| 15 |
| 0 |
|
| 2011-11-11 | | transcript level | | | | | | | 1 |
| 15 |
| 0 |
|
| 2011-08-23 | | transcript level | | | | | | | 1 |
| 15 |
| 0 |
|
|
| |
|
| Protein Isoforms |
|
| |
| |
|
| : Uniquely mapped peptide | | : Gene-specific peptide | | : Shared peptide |
|
|
| |
|
| Interacting Partners |
|
| |
|
| No. |
Exp. ref. |
Symbol |
|
PE |
Pr |
Ab |
Di |
|
GO: Biological Process |
GO: Mulecular Function |
GO: Cellular Component |
|
| 1 |
EBI-3919450,EBI-743771 |
APPBP2 |
|
| | | | |
.intracellular transport
.metabolic process
.intracellular protein transport |
.microtubule motor activity |
.cytoplasmic vesicle membrane
.microtubule associated complex
.microtubule
+ 2 more... |
|
|
| |
|
| EST expression level of Protein Coding Gene (ref. NCBI UniGene EST) |
|
| |
|
| Body Sites | |
| Tissues | TPM* | |
|
| brain | 21 | |
| cervix | 144 | |
| connective tissue | 6 | |
| eye | 19 | |
| heart | 44 | |
| intestine | 8 | |
| kidney | 28 | |
| larynx | 42 | |
| liver | 4 | |
| lung | 32 | |
| mammary gland | 39 | |
| muscle | 18 | |
| ovary | 49 | |
| pancreas | 9 | |
| placenta | 17 | |
| prostate | 42 | |
| skin | 23 | |
| stomach | 41 | |
| testis | 6 | |
| thymus | 12 | |
| thyroid | 64 | |
| trachea | 19 | |
| uterus | 30 | |
|
| Health State | |
| Tissues | TPM* | |
|
| normal | 21 | |
| bladder carcinoma | 56 | |
| breast (mammary gland) tumor | 42 | |
| cervical tumor | 86 | |
| colorectal tumor | 8 | |
| gastrointestinal tumor | 25 | |
| germ cell tumor | 3 | |
| head and neck tumor | 14 | |
| leukemia | 10 | |
| liver tumor | 10 | |
| lung tumor | 9 | |
| non-neoplasia | 41 | |
| ovarian tumor | 26 | |
| pancreatic tumor | 9 | |
| prostate cancer | 9 | |
| retinoblastoma | 21 | |
| skin tumor | 23 | |
| uterine tumor | 44 | |
|
| Developmental Stage | |
| Tissues | TPM* | |
|
| adult | 19 | |
| fetus | 14 | |
|
TPM*: Transcripts per million; transcript expression level measured by expression sequence tags. |
| |
|
| Expression level of Protein (ref. Human Protein Atlas) |
|
| |
|
| RNA-Seq. | |
| Tissues | FPKM | |
|
| adipose tissue | 10.8 | |
| adrenal gland | 11.7 | |
| appendix | 5.1 | |
| bone marrow | 4.7 | |
| cerebral cortex | 2.3 | |
| colon | 6.3 | |
| duodenum | 6 | |
| esophagus | 3 | |
| gallbladder | 8.5 | |
| heart muscle | 8.3 | |
| kidney | 7.7 | |
| liver | 8.9 | |
| lung | 8.6 | |
| lymph node | 9.4 | |
| ovary | 11.1 | |
| pancreas | 2.9 | |
| placenta | 5.1 | |
| prostate | 14.2 | |
| salivary gland | 17.8 | |
| skin | 5.6 | |
| small intestine | 5.9 | |
| spleen | 9.3 | |
| stomach | 6.4 | |
| testis | 5.6 | |
| thyroid gland | 12.8 | |
| urinary bladder | 5.5 | |
|
| Cancer | |
| Tumor | Number of patients and Staining levels | |
| breast cancer | |
| carcinoid | |
| cervical cancer | |
| colorectal cancer | |
| endometrial cancer | |
| glioma | |
| head and neck cancer | |
| liver cancer | |
| lung cancer | |
| lymphoma | |
| melanoma | |
| ovarian cancer | |
| pancreatic cancer | |
| prostate cancer | |
| renal cancer | |
| skin cancer | |
| stomach cancer | |
| testis cancer | |
| thyroid cancer | |
| urothelial cancer | |
|
| RNA-seq colour codes |
|
|
Highly expressed RNAs (FPKM >50) | |
|
Moderately expressed RNAs (50> FPKM >10) | |
|
Lower expressed RNAs (10> FPKM >1) | |
|
The lowest expressed RNAs (FPKM value of 0 or 1) |
|
| Staining level colour codes |
|
|
Highly expressed protein | |
|
Moderately expressed protein | |
|
Lower expressed protein | |
|
Not Detected |
|
|
| |
|
> Protein (NX_Q8N2H3)